Femtech World reveals AI innovation award shortlist

Femtech World is excited to reveal the shortlist for this year’s AI Innovation award.

The honour is one of 10 being celebrated at Femtech World’s third annual awards event.

The AI Innovation award, sponsored by Women’s Health Week, honours the individuals and organisations using AI to do something genuinely difficult: make healthcare work better for women.

Women’s Health Week’s flagship women’s health conferences across Europe and the USA unite the complete ecosystem – visionary founders, strategic investors, multinational corporations and specialised service providers – accelerating life-changing solutions that address women’s most critical unmet health needs.

The AI Innovation award celebrates groundbreaking innovation in diagnosis, treatment accessibility and health outcomes and a clear commitment to building a more inclusive and equitable healthcare future.

This year’s shortlist reflects exactly that ambition.

The three entries will now be judged be a representative from Women’s Health Week, with the winner announced at a virtual event on June 19.

Congratulations to the shortlist and many thanks to everyone who entered.

AI Innovation Shortlist

 

For millions of women, years of dismissed symptoms end at the same wall: “Your labs are normal.” Diadia was built for those women – and the clinicians who want to help them but have been let down by inadequate tools.

Founded by Dr. Elena Ikonomovska, whose own experience of years of unresolved symptoms drove her from a career building AI at Google to building it for women’s health, Diadia is a genetics-informed AI clinical reasoning platform.

It analyses nearly one million genetic variants, over 200 biomarkers, and more than 310,000 peer-reviewed research papers simultaneously – identifying root causes in complex hormonal, metabolic, and endocrine cases that standard medicine routinely misses.

Developed by ParrotPal Group and anchored at the University of Cambridge, LeanShield is a domain-specific foundational AI model addressing one of the most underrecognised risks in women’s health: muscle loss driven by declining oestrogen during perimenopause.

LeanShield generates a single 0–100 muscle safety score from data women already produce. No clinic visit. No prescription.

Trained on the intersection of nutritional behaviour, training compliance, body composition and medication protocols, it is, in the words of its creators, the measurement standard women’s metabolic health has never had.

PeriGen’s technology stands out as a transformative force in maternal healthcare, using artificial intelligence to address one of the most urgent and persistent challenges in medicine: preventable complications during pregnancy and childbirth. 

With more than 80 per cent of pregnancy-related deaths considered preventable, PeriGen’s PeriWatch Vigilance platform delivers real-time clinical decision support by continuously analysing maternal and foetal data.

This enables care teams to detect early warning signs and intervene faster, particularly in high-stakes labour and delivery settings where seconds matter.

By turning complex data into actionable insights, the technology helps standardise care and reduce variability across providers and institutions.